Testing Novel Drug Design Engines for Cancer for Improved Efficacy and Toxicity Mitigation

• Exploring the challenges of delivering RNAi to cancer
• Evaluating potential strategies to enable the development of RNAi-based drugs
• Presenting examples of emerging RNAi-based therapeutics for cancer

Speakers:

Zdravka Medarova

Chief Technology Officer & Co-Founder

TransCode Therapeutics